Feladilimab (Anti-ICOS/CD278 Reference Antibody (feladilimab); GSK3359609) 是人源化的 IgG4，为抗 ICOS 激动剂单克隆抗体。Feladilimab 与表达 ICOS 的 T 细胞结合。Feladilimab 具有癌症研究的潜力。
| 生物活性 | Feladilimab (Anti-ICOS/CD278 Reference Antibody (feladilimab); GSK3359609) is humanizedIgG4anti-ICOS agonist monoclonal antibody. Feladilimab binds to ICOS-expressing T cells. Feladilimab has the potential for the research ofcancer[1]. |
| CAS 号 | |
| 储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |
m.cnreagent.com